modelbased drug development: roles and applications of pk/pd modeling and simulation (Pfizer Inc)
90
Structured Review
Pfizer Inc
modelbased drug development: roles and applications of pk/pd modeling and simulation
Modelbased Drug Development: Roles And Applications Of Pk/Pd Modeling And Simulation, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd+simulation+model/modelbased+drug+development++roles+and+applications+of+pk+pd+modeling+and+simulation/pm24138620-70-17-3
Average 90 stars, based on 1 article reviews
Modelbased Drug Development: Roles And Applications Of Pk/Pd Modeling And Simulation, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd+simulation+model/modelbased+drug+development++roles+and+applications+of+pk+pd+modeling+and+simulation/pm24138620-70-17-3
Average 90 stars, based on 1 article reviews
modelbased drug development: roles and applications of pk/pd modeling and simulation - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Conference report: reviving pharmaceutical R&D with translational science, regulatory efficiency and innovative models. Article Snippet: 10.4155/BIO.13.235 © 2013 Future Science Ltd Naidong Weng of Janssen Pharmaceuticals (NJ, USA) served as the CPSA Shanghai 2013 Program Chair.. Naidong Weng, along with the CPSA founder, Mike Lee of Milestone Development Services (PA, USA), opened the conference by welcoming the participants and passing on thanks to the organizing commit tee members, session chairs and volunteers.. The theme of the CPSA Shanghai 2013 was ‘Reviv ing Pharmaceutical R&D with Translational Science, Regulatory Efficiency, and Innovative Models’, which was echoed in the two plenary lectures given by John Newton of Sanofi (PA, USA) on: ‘The Impact of Metabolism and Pharmaco kinetics in Translational Medicine: What Innovation Has Brought Us and What Challenges Still Exist?’ and by Ian A Blair of University of Pennsylvania (PA, USA) on: ‘Bio marker Discovery and V alidation: Challenges and Promises,’ respectively. |